...
首页> 外文期刊>Archivum Immunologiae et Therapiae Experimentalis >Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer
【24h】

Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer

机译:细胞因子对CD8 + T淋巴细胞的抗原非特异性激活:与免疫,自身免疫和癌症的相关性

获取原文
获取原文并翻译 | 示例
           

摘要

Development of T lymphocytes and their survival in the periphery are dependent on signals emanating from cytokine receptors as well as the T cell antigen receptor (TCR). These two signaling pathways play distinct and complementary roles at various stages of T cell development, maturation, survival, activation and differentiation. During immune response to foreign antigens initiated by TCR signaling, cytokines play a key role in the expansion of activated T cells. Even though the initial activation of T cells occurs via the TCR, this requirement can be overcome under certain circumstances. During lymphopenia, cytokines trigger memory CD8+ T cells to undergo antigen non-specific homeostatic expansion, whereas naïve CD8+ T cells require both cytokines and TCR signaling. Recent reports show certain combinations of cytokines can induce proliferation and effector functions of naïve CD8+ T cells without concomitant stimulation via the TCR. While such antigen non-specific stimulation of naïve T cells might significantly boost the adaptive immune response, it could also have an undesirable effect of triggering potentially autoreactive cells. Understanding the mechanisms and the regulation of cytokine-driven stimulation of naïve CD8+ T cells may lead to novel strategies of intervention for autoimmune diseases. On the other hand, in vitro expansion of naïve CD8+ T cells by certain combinations of cytokines could be used to generate tumor-specific cells with ideal properties for cellular immunotherapy of cancer. Keywords: CD8+ T lymphocytes - cytokines - immune response - autoimmunity - cancer Received: 2008.05.02, Accepted: 2008.07.28
机译:T淋巴细胞的发育及其在外周的存活取决于细胞因子受体以及T细胞抗原受体(TCR)发出的信号。这两种信号通路在T细胞发育,成熟,存活,激活和分化的各个阶段起着独特而互补的作用。在对由TCR信号启动的外源抗原的免疫应答过程中,细胞因子在活化T细胞的扩增中起关键作用。即使T细胞的初始激活是​​通过TCR发生的,在某些情况下也可以克服这一要求。在淋巴细胞减少症期间,细胞因子触发记忆性CD8 + T细胞经历抗原非特异性稳态扩增,而幼稚的CD8 + T细胞既需要细胞因子,也需要TCR信号传导。最近的报道表明,某些细胞因子组合可以诱导幼稚的CD8 + T细胞的增殖和效应功能,而不会伴随TCR的刺激。尽管这种抗原对幼稚T细胞的非特异性刺激可能会显着增强适应性免疫反应,但它也可能具有触发潜在的自身反应性细胞的不良作用。了解细胞因子驱动的初始CD8 + T细胞的机制和调控可能会导致针对自身免疫性疾病的新干预策略。另一方面,可以通过某些细胞因子的组合在体外扩增天然CD8 + T细胞,以产生具有理想特性的肿瘤特异性细胞,用于癌症的细胞免疫治疗。关键词:CD8 + T淋巴细胞-细胞因子-免疫应答-自身免疫性-癌症收稿日期:2008.05.02,接受日期:2008.07.28

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号